The Summary
This systematic review and meta-analysis of 33 randomized controlled trials, involving 3,476 participants, evaluated the Mediterranean diet's effect on inflammatory and oxidative stress biomarkers. Researchers found that adopting the diet led to significant reductions in high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), and interleukin-17 (IL-17) compared to control diets. Subgroup analyses indicated that these anti-inflammatory benefits were particularly pronounced in participants under 60, those with cardiovascular disease, and during interventions lasting less than 12 weeks. However, no significant changes were observed for general CRP, TNF-alpha, or total antioxidant capacity.
Why this is interesting
While the health benefits of the Mediterranean diet are widely celebrated, clinical evidence of its direct impact on inflammation has previously been inconsistent. This study provides concrete proof that the diet actively lowers key inflammatory markers like hs-CRP and IL-6, which drive heart disease and diabetes. Crucially, the benefits appeared rapidly—often in under 12 weeks—and were highly effective for those with existing cardiovascular disease. For readers, this means making simple dietary shifts toward whole grains, olive oil, and fish can deliver rapid, measurable protection against chronic inflammation.